Clal Biotechnology Industries Ltd. (TLV: CBI)

Market Cap	60.86M
Revenue (ttm)	32.00K
Net Income (ttm)	-74.74M
Shares Out	156.85M
EPS (ttm)	-0.43
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,945
Open	38.60
Previous Close	38.60
Day's Range	38.60 - 39.00
52-Week Range	29.00 - 54.60
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CBI

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through per...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Country: Israel
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: CBI

Financial Performance

In 2023, CBI's revenue was 104,000, a decrease of -71.89% compared to the previous year's 370,000. Losses were -31.05 million, -49.71% less than in 2022.